126 related articles for article (PubMed ID: 7371346)
1. Bone scans in bone metastases from functioning thyroid carcinoma.
Castillo LA; Yeh SD; Leeper RD; Benua RS
Clin Nucl Med; 1980 May; 5(5):200-9. PubMed ID: 7371346
[TBL] [Abstract][Full Text] [Related]
2. [Skeletal metastases from differentiated thyroid carcinomas. Radiographic appearances, scans, course during treatment].
Wiebe V; Erbe W
Fortschr Geb Rontgenstr Nuklearmed; 1973 Mar; 118(3):313-9. PubMed ID: 4691617
[No Abstract] [Full Text] [Related]
3. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
4. [Dynamics of the x-ray picture of bone metastases of thyroid cancer as affected by radiotherapy].
Kiseleva ES; Zvekotkina LS; Babushkin VV
Med Radiol (Mosk); 1989 Mar; 34(3):6-10. PubMed ID: 2927278
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the therapeutic dose and diagnostic dose of 131I in the detection of metastatic foci of differentiated thyroid cancer.
Tung CC; Chang TC; Su CT; Chen FW; Chang CC
Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1081-5. PubMed ID: 3235967
[No Abstract] [Full Text] [Related]
6. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
[TBL] [Abstract][Full Text] [Related]
8. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma.
Dadparvar S; Krishna L; Brady LW; Slizofski WJ; Brown SJ; Chevres A; Micaily B
Cancer; 1993 Jun; 71(11):3767-73. PubMed ID: 8490927
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
11. A Clear Cell Variant of Papillary Thyroid Microcarcinoma With Lung, Bone, and Soft Tissue Metastases.
Yazici B; Ertan Y; Oral A; Akgün A
Clin Nucl Med; 2015 Nov; 40(11):885-7. PubMed ID: 26018685
[TBL] [Abstract][Full Text] [Related]
12. [Detection of bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. I. Incidence of bone metastases from bronchogenic carcinoma and their prognosis (author's transl)].
Fujimura N
Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Nov; 38(11):1054-63. PubMed ID: 733476
[No Abstract] [Full Text] [Related]
13. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
Fatourechi V; Hay ID; Mullan BP; Wiseman GA; Eghbali-Fatourechi GZ; Thorson LM; Gorman CA
Thyroid; 2000 Jul; 10(7):573-7. PubMed ID: 10958309
[TBL] [Abstract][Full Text] [Related]
14. Sustained and diffuse 131I avid bone metastases with low thyroglobulin levels in a patient with papillary thyroid carcinoma.
Zhao CL; Qiu ZL; Chen LB; Yuan ZB; Luo QY
Clin Nucl Med; 2013 May; 38(5):375-7. PubMed ID: 23567283
[TBL] [Abstract][Full Text] [Related]
15. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
16. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
17. Frequency of hepatic visualization during I-131 imaging for metastatic thyroid carcinoma.
Rosenbaum RC; Johnston GS; Valente WA
Clin Nucl Med; 1988 Sep; 13(9):657-60. PubMed ID: 3180614
[TBL] [Abstract][Full Text] [Related]
18. Bone and liver scans in patients with head and neck carcinoma.
Belson TP; Lehman RH; Chobanian SL; Malin TC
Laryngoscope; 1980 Aug; 90(8 Pt 1):1291-6. PubMed ID: 7401829
[TBL] [Abstract][Full Text] [Related]
19. Nonosseous uptake on bone scan in adenocarcinoma of unknown primary origin.
Chen X; Jacobson AF
Clin Nucl Med; 2000 Sep; 25(9):751-2. PubMed ID: 10983778
[No Abstract] [Full Text] [Related]
20. Functioning Metastases from Thyroid Papillary Carcinoma in Bone.
Biyi A; Zaïmi S; Doudouh A
J Nucl Med Technol; 2016 Dec; 44(4):253-254. PubMed ID: 27363445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
